Sign in
4/A

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-003639

Options or other derivatives

  • Chief Financial Officer acquired 18,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
D'Ambrosio Donald Eric Chief Financial Officer 2017-09-18 Grant or award · Employee Stock Option (right to purchase) +18,000 18,000 D
Loading xslF345X03/s110117_form4a.xml…